Pulmonx (LUNG) Payables (2019 - 2025)

Pulmonx (LUNG) has 7 years of Payables data on file, last reported at $4.0 million in Q4 2025.

• Quarterly Payables fell 42.72% year-over-year to $4.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $4.0 million (down 42.72% YoY) and the FY2025 annual result came in at $4.0 million, down 42.72% from the prior year.
• Payables retreated to $4.0 million in Q4 2025 per LUNG's latest filing, from $6.5 million in the prior quarter.
• Across five years, Payables topped out at $18.9 million in Q4 2021 and bottomed at $1.8 million in Q4 2022.
• The 5-year median for Payables is $6.0 million (2022), against an average of $7.8 million.
• The widest annual swing landed in 2022, when Payables slumped 90.23%; it then surged 180.31% in 2024.
• Tracing LUNG's Payables over 5 years: stood at $18.9 million in 2021, then tumbled by 90.23% to $1.8 million in 2022, then soared by 97.62% to $3.7 million in 2023, then jumped by 91.76% to $7.0 million in 2024, then sank by 42.72% to $4.0 million in 2025.
• Per Business Quant, the three latest LUNG Payables figures stand at $4.0 million (Q4 2025), $6.5 million (Q3 2025), and $6.7 million (Q2 2025).

Peer Comparison